| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1530 | 2019 |
| Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis MA Van Es, HJ Schelhaas, PWJ Van Vught, N Ticozzi, PM Andersen, ... Annals of neurology 70 (6), 964-973, 2011 | 212 | 2011 |
| Advances in Parkinson’s disease: 200 years later NLG Del Rey, A Quiroga-Varela, E Garbayo, I Carballo-Carbajal, ... Frontiers in neuroanatomy 12, 113, 2018 | 161 | 2018 |
| Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's disease T Botta‐Orfila, X Morató, Y Compta, JJ Lozano, N Falgas, F Valldeoriola, ... Journal of neuroscience research 92 (8), 1071-1077, 2014 | 157 | 2014 |
| Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients R Fernández‐Santiago, I Carballo‐Carbajal, G Castellano, R Torrent, ... EMBO Molecular Medicine, e201505439, 2015 | 138 | 2015 |
| Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ... JAMA neurology 78 (4), 464-472, 2021 | 116 | 2021 |
| Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's disease C Marras, RN Alcalay, C Caspell‐Garcia, C Coffey, P Chan, JE Duda, ... Movement Disorders 31 (8), 1192-1202, 2016 | 115 | 2016 |
| Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset KJ Billingsley, IA Barbosa, S Bandrés-Ciga, JP Quinn, VJ Bubb, ... npj Parkinson's Disease 5 (1), 8, 2019 | 99 | 2019 |
| Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the− 2578AA genotype D Lambrechts, K Poesen, R Fernandez-Santiago, A Al-Chalabi, R Del Bo, ... Journal of medical genetics 46 (12), 840-846, 2009 | 88 | 2009 |
| Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers C Pont-Sunyer, A Iranzo, C Gaig, A Fernández-Arcos, D Vilas, ... PloS one 10 (7), e0132368, 2015 | 87 | 2015 |
| Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis R Fernández-Santiago, S Hoenig, P Lichtner, AD Sperfeld, M Sharma, ... Journal of neurology 256, 1337-1342, 2009 | 76 | 2009 |
| Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS M Synofzik, D Ronchi, I Keskin, AN Basak, C Wilhelm, C Gobbi, A Birve, ... Human molecular genetics 21 (16), 3568-3574, 2012 | 72 | 2012 |
| Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance M San Luciano, CM Tanner, C Meng, C Marras, SM Goldman, AE Lang, ... Movement Disorders 35 (10), 1755-1764, 2020 | 68 | 2020 |
| MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients E Tolosa, T Botta-Orfila, X Morató, C Calatayud, R Ferrer-Lorente, ... Neurobiology of aging 69, 283-291, 2018 | 65 | 2018 |
| Micro RNA association with synucleinopathy conversion in rapid eye movement behavior disorder R Fernández‐Santiago, A Iranzo, C Gaig, M Serradell, M Fernández, ... Annals of Neurology 77 (5), 895-901, 2015 | 63 | 2015 |
| Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score H Iwaki, C Blauwendraat, MB Makarious, S Bandrés‐Ciga, HL Leonard, ... Movement Disorders 35 (5), 774-780, 2020 | 61 | 2020 |
| The MC1R melanoma risk variant p.R160W is associated with Parkinson disease G Tell‐Marti, JA Puig‐Butille, M Potrony, C Badenas, M Mila, J Malvehy, ... Annals of neurology 77 (5), 889-894, 2015 | 61 | 2015 |
| HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease C Gaig, G Ercilla, X Daura, M Ezquerra, R Fernández-Santiago, E Palou, ... Neurology: Neuroimmunology & Neuroinflammation 6 (6), e605, 2019 | 58 | 2019 |
| The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging Studies C Pont‐Sunyer, E Tolosa, C Caspell‐Garcia, C Coffey, RN Alcalay, ... Movement Disorders 32 (5), 726-738, 2017 | 56 | 2017 |
| The genetic architecture of Parkinson disease in Spain: characterizing population‐specific risk, differential haplotype structures, and providing etiologic insight S Bandres‐Ciga, S Ahmed, MS Sabir, C Blauwendraat, ... Movement Disorders 34 (12), 1851-1863, 2019 | 54 | 2019 |
Mario EzquerraIDIBAPS, Fundacio Clinic de BarcelonaVerified email at clinic.ub.es
